(Q46519355)

22 December 2017

title

Relationship between circulating FGF23 and total body atherosclerosis in the community (English)

1 reference

22 December 2017

1 reference

6

Lars Lind

1 reference

22 December 2017

5

Anders Larsson

1 reference

22 December 2017

4

Håkan Ahlström

1 reference

22 December 2017

3

Lars Johansson

1 reference

22 December 2017

1

Majd A I Mirza

1 reference

22 December 2017

author name string

Tomas Hansen

series ordinal

2

1 reference

22 December 2017

Tobias E Larsson

series ordinal

7

1 reference

22 December 2017

language of work or name

English

0 references

publication date

9 May 2009

1 reference

22 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

22 December 2017

volume

24

1 reference

22 December 2017

issue

10

1 reference

22 December 2017

page(s)

3125-3131

1 reference

22 December 2017

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Role of fibroblast growth factor 23 in health and in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Whole-body magnetic resonance angiography of patients using a standard clinical scanner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Whole body MR angiography screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

The prevalence and quantification of atherosclerosis in an elderly population assessed by whole-body magnetic resonance angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

FGF-23 in patients with end-stage renal disease on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Serum FGF23 levels in normal and disordered phosphorus homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

Pathophysiology of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP205

21 January 2018

Identifiers

DOI

10.1093/NDT/GFP205

1 reference

22 December 2017

1 reference

22 December 2017